TRANSPHORM INC shareholders Q3 2023

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

TRANSPHORM INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,619,558$10,255,4194.85%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$50,340,6761.77%
Worth Venture Partners, LLC 1,152,278$2,558,0571.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,084$555,1870.78%
Black Maple Capital Management LP 63,923$141,9090.10%
Taylor Frigon Capital Management LLC 62,500$138,7500.08%
Polar Asset Management Partners Inc. 1,009,702$2,241,5380.05%
Soros Fund Management 340,000$754,8000.01%
AMERIPRISE FINANCIAL INC 4,443,329$9,864,1910.00%
Stratos Wealth Partners, LTD. 25,640$56,9210.00%
FMR LLC 1,578$3,5030.00%
AMERICAN INTERNATIONAL GROUP, INC. 14,043$31,1750.00%
BANK OF AMERICA CORP /DE/ 17,666$39,2190.00%
WELLS FARGO & COMPANY/MN 5,578$12,3830.00%
NORTHERN TRUST CORP 221,467$491,6560.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Legal & General Group Plc 3,514$7,8010.00%
GEODE CAPITAL MANAGEMENT, LLC 471,286$1,046,3770.00%
STATE STREET CORP 406,328$902,0480.00%
NEW YORK STATE COMMON RETIREMENT FUND 6,440$140.00%
External links

This page lists TRANSPHORM INC's shareholders in Q3 2023. To view TRANSPHORM INC's shareholder history, click here.